Navigation Links
EBI OsteoGen Implantable Bone Growth Stimulator

ProductsEBI OsteoGen Implantable Bone Growth Stimulator
Company Biomet, Inc.
Item EBI OsteoGen Implantable Bone Growth Stimulator
Features 
  • Totally surgically implanted
  • Compatible with bone graft surgery in the surgical treatments (internal and external fixation) commonly used for the management of nonunions such as transverse, segmented, and comminuted
  • May be used as an adjunct to internal/external fixation and allograft/autograft
  • Description The EBI OsteoGen surgically implanted bone growth stimulator is a useful adjunct for the treatment of nonunions when surgery is already planned or when patient compliance may be a concern. Because the OsteoGen is totally surgically implanted, patients are assured of therapeutic treatment directly at the nonunion site 24 hours a day for up to 6 months.

    The OsteoGen bone growth stimulator is commonly used for nonunions in the following areas: femur, tibia, fibula, humerus, clavicle, ulna, radius.
    Info Biomet, Inc.
    Customer Service: 1-800-526-2579
    Web site: http://www.ebimedical.com/

    Related medicine products :

    1. EBI OsteoGen™-M (Mesh Cathode)
    2. EBI OsteoGen-M
    3. EBI OsteoGen
    4. EBI OsteoGen-D
    5. Autologous Growth Factors
    6. IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor
    7. Human Growth Hormone EIA Endocrine Function 025-BC-1033
    8. IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
    9. Physio-Stim Bone Growth Stimulator
    10. OL1000 Bone Growth Stimulators
    11. SpinaLogic Bone Growth Stimulator
    ...methanol for faster, more complete staining of blo...manufacturing process yields a stain that rapidly ...efinition of cytoplasmic structure, distinct nucle...ng smear. Used as a differential stain for: blood ...
    ...for stat, routine or back-up staining. Developed t...one marrow (20-30 seconds). Our unique manufacturi...les which yield excellent color intensity and morp...he steps involved in the Wright's staining procedu...
    Hema-Quik II
    ...l for stat, routine or back-up staining. Developed...r unique manufacturing process generates finely di...r intensity and morphological differentiation. It ...t's staining procedure and includes the buffer wit...
    Medicine Products:
    (Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be avail...acility. , Toronto, ON (...nt and CEO of Therapure Biopharma Inc. today annou...ercial scale pharmaceutical grade freeze dryer and...yophilization) available for contract manufacturin...
    (Date:11/8/2009)...s not mean the battle is won," said Dr. Charmaine ...swire/ -- In a vote of 240-194, the Stupak-Ellswor...t to prohibit abortion mandates and funding in HR ...ited for Life Action President and CEO Dr. Charmai... victory for the pro-life Americans across this co...
    (Date:11/8/2009)...Passage of H.R. 3961 to Secure the Stability of Me...re/ -- Statement Attributable to: J. James Rohack,..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...ge of the House health reform bill, which will hel...cians and calls for swift passage of H.R. 3961 to ...
    (Date:11/8/2009)...se Passage of Health Care Reform Bill ,, Crit...e coverage for all Americans ,, BALTIMORE, Nov...the United States House of Representatives passed ... strengthen Medicare for seniors and end discrimin...of Americans out of affordable health coverage. ,...
    (Date:11/7/2009)... The American Medical As...sh Award for Citizenship and Community Service to ...ago, IL. The award recognizes physicians who have ...uty to make an outstanding public service contribu...the award today during the opening session of the ...
    Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
    ...uster Active Noise Reduction Earmuff Delivers Best...The NoiseBuster Active Noise Reduction ("ANR") Saf... noise generated by lawn, landscape and garden pow...scape construction, sports-field site development ...
    ... 23 Consider how these outlooks could free you fr... change the way you look at them. , Problems... , , , "Thus I Became Stress Free, Oh Really?...and happiness. Written from the inspiration Joshi ...
    ...alist HIDI(TM) process at the 2009 Annual Congress..., , SEATTLE, March 23 Hospital executives find t...ith almost 50 percent of America,s hospitals now o...y and retaining physicians and caregivers. The cha...
    ...orphotek(R), Inc., a subsidiary of Eisai Corporati... Food and Drug Administration (FDA) has agreed to ...e III clinical trial evaluating farletuzumab (also... Assessment (SPA) procedure. , , "We are pleased ...
    ...h.D. Honored for Distinguished Service in the Fiel...NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY... Frederick Hawthorne, Ph.D., a member of the Compa...r. Hawthorne, who is co-director of the Internatio...
    ...wire-FirstCall/ - Transition Therapeutics Inc. ("T...TTH) announced today that the first patient has be...T-223 in combination with a proprietary Lilly GLP-...ate the safety, tolerability and efficacy of daily...
    Other Medicine News:Health News:NoiseBuster(R) Safeguards Hearing by Utilizing Cutting-Edge Technology to Attenuate Power Equipment Noise 2Health News:'Thus I Became Stress Free, Oh Really?': Systematically Manage and Optimize Stress to Improve Productivity, Happiness 2Health News:Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care 2Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 2Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 3Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 4Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 2Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 3Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2
    (Date:11/6/2009)...wswire/ -- Trius Therapeutics, Inc. announced toda...rm S-1 with the U.S. Securities and Exchange Commi...offering of shares of its common stock. All shares...ll be offered by the Company. ,, Credit Suisse ...g manager, Piper Jaffray & Co. is acting as co...
    (Date:11/6/2009)... Roper Industries, Inc. ...a definitive agreement to acquire Verathon, Inc., ... The Verathon Board of Directors has approved the...ry regulatory approvals and closing conditions, in...the closing to be completed in early December. ,...
    (Date:11/6/2009)... Derma Sciences, Inc. ...ed wound care products, announced plans to release...onday, November 16, 2009. The Company will hold a ...ts at 11:00 am EST. Interested parties should call...rnational), with passcode 81416481 to access the c...
    Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Labopharm Reports Results for Second Quarter Fiscal 2009 53931 1Labopharm Reports Results for Second Quarter Fiscal 2009 53931 2Labopharm Reports Results for Second Quarter Fiscal 2009 53931 3Labopharm Reports Results for Second Quarter Fiscal 2009 53931 4Labopharm Reports Results for Second Quarter Fiscal 2009 53931 5Labopharm Reports Results for Second Quarter Fiscal 2009 53931 6Labopharm Reports Results for Second Quarter Fiscal 2009 53931 7Labopharm Reports Results for Second Quarter Fiscal 2009 53931 8Labopharm Reports Results for Second Quarter Fiscal 2009 53931 9Labopharm Reports Results for Second Quarter Fiscal 2009 53931 10Labopharm Reports Results for Second Quarter Fiscal 2009 53931 11Labopharm Reports Results for Second Quarter Fiscal 2009 53931 12Labopharm Reports Results for Second Quarter Fiscal 2009 53931 13Labopharm Reports Results for Second Quarter Fiscal 2009 53931 14Labopharm Reports Results for Second Quarter Fiscal 2009 53931 15Mother 26 Daughter Celebrate Victory Over Meth 53930 1Mother 26 Daughter Celebrate Victory Over Meth 53930 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 1Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 4